Vir Biotechnology (VIR, $10.39) was one of top quarterly gainers, jumping +1 to $10.39 per share. A.I.dvisor analyzed 912 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases